Bladder Cancer Advocacy Network

Awardees are being recognized for creative approaches to accelerating progress in bladder cancer research.

The Bladder Cancer Advocacy Network provides insight into the ongoing cisplatin shortage.

Outstanding early-career researchers acknowledged for novel studies to enhance the well-being of patients with bladder cancer.

Roger Li, MD, Moffit Cancer Center, was awarded the grant to study the novel oncolytic virus drug CG0070 in patients with intermediate-risk non–muscle-invasive bladder cancer.

First-ever offering will help bladder cancer patients, caregivers and survivors cope with the disease.

Applicants may be working in basic, translational, clinical, epidemiologic, bioengineering sciences or any other field, but projects must be specific to bladder cancer and/or upper tract urothelial carcinoma.

BCAN’s Young Investigator Awards support outstanding early-career scientists and clinical cancer researchers with a demonstrated commitment to improving the understanding and treatment of bladder cancer and/or upper tract urothelial cancer.